*** CHEMICAL IDENTIFICATION ***
RTECS NUMBER : AR9100000
CHEMICAL NAME : Acridine, 9-(p-dimethylaminoanilino)-
CAS REGISTRY NUMBER : 13365-38-3
BEILSTEIN REFERENCE NO. : 0487364
LAST UPDATED : 199612
DATA ITEMS CITED : 7
MOLECULAR FORMULA : C21-H19-N3
MOLECULAR WEIGHT : 313.43
WISWESSER LINE NOTATION : T C666 BNJ IMR DN1&1
COMPOUND DESCRIPTOR : Drug
Mutagen
SYNONYMS/TRADE NAMES :
* Acridine, 9-((p-(dimethylamino)phenyl)amino)-
* N'-9-Acridinyl-N,N-dimethyl-1,4-benzenediamine
* 1,4-Benzenediamine, N'-9-acridinyl-N,N-dimethyl-
* 9-(p-Dimethylaminoanilino)acridine
* 9-((p-(Dimethylamino)phenyl)amino)acridine
* NSC 13002
* WIN 1701
*** HEALTH HAZARD DATA ***
** ACUTE TOXICITY DATA **
TYPE OF TEST : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE : Intravenous
SPECIES OBSERVED : Rodent - rat
DOSE/DURATION : 15 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
NCIAL* Progress Report Submitted to the National Cancer Institute by Arthur
D. Little, Inc. (15 Acorn Park, Cambridge, MA 02140)
Volume(issue)/page/year: -,326,1967
TYPE OF TEST : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE : Intraperitoneal
SPECIES OBSERVED : Rodent - mouse
DOSE/DURATION : 80970 ug/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
NCISP* National Cancer Institute Screening Program Data Summary,
Developmental Therapeutics Program. (Bethesda, MD 20205)
Volume(issue)/page/year: JAN1986
TYPE OF TEST : LDLo - Lowest published lethal dose
ROUTE OF EXPOSURE : Intravenous
SPECIES OBSERVED : Mammal - dog
DOSE/DURATION : 5 mg/kg
TOXIC EFFECTS :
Behavioral - convulsions or effect on seizure threshold
Behavioral - ataxia
Gastrointestinal - changes in structure or function of salivary glands
REFERENCE :
NCIAL* Progress Report Submitted to the National Cancer Institute by Arthur
D. Little, Inc. (15 Acorn Park, Cambridge, MA 02140)
Volume(issue)/page/year: -,326,1967
TYPE OF TEST : LDLo - Lowest published lethal dose
ROUTE OF EXPOSURE : Intravenous
SPECIES OBSERVED : Primate - monkey
DOSE/DURATION : 5 mg/kg
TOXIC EFFECTS :
Sense Organs and Special Senses (Eye) - mydriasis (pupillary dilation)
Behavioral - convulsions or effect on seizure threshold
Cardiac - pulse rate
REFERENCE :
NCIAL* Progress Report Submitted to the National Cancer Institute by Arthur
D. Little, Inc. (15 Acorn Park, Cambridge, MA 02140)
Volume(issue)/page/year: -,326,1967
** OTHER MULTIPLE DOSE TOXICITY DATA **
TYPE OF TEST : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE : Intravenous
SPECIES OBSERVED : Mammal - dog
DOSE/DURATION : 35 mg/kg/28D-I
TOXIC EFFECTS :
Cardiac - arrhythmias (including changes in conduction)
Lungs, Thorax, or Respiration - fibrosis, focal (pneumoconiosis)
Gastrointestinal - changes in structure or function of salivary glands
REFERENCE :
NCIAL* Progress Report Submitted to the National Cancer Institute by Arthur
D. Little, Inc. (15 Acorn Park, Cambridge, MA 02140)
Volume(issue)/page/year: -,326,1967
TYPE OF TEST : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE : Intravenous
SPECIES OBSERVED : Primate - monkey
DOSE/DURATION : 35 mg/kg/28D-I
TOXIC EFFECTS :
Lungs, Thorax, or Respiration - fibrosis, focal (pneumoconiosis)
Gastrointestinal - changes in structure or function of salivary glands
Blood - pigmented or nucleated red blood cells
REFERENCE :
NCIAL* Progress Report Submitted to the National Cancer Institute by Arthur
D. Little, Inc. (15 Acorn Park, Cambridge, MA 02140)
Volume(issue)/page/year: -,326,1967
** MUTATION DATA **
TYPE OF TEST : DNA damage
TEST SYSTEM : Mammal - species unspecified Lymphocyte
DOSE/DURATION : 2 umol/L
REFERENCE :
JMCMAR Journal of Medicinal Chemistry. (American Chemical Soc.,
Distribution Office Dept. 223, POB POB 57136, West End Stn., Washington, DC
20037) V.6- 1963- Volume(issue)/page/year: 24,170,1981
*** END OF RECORD ***